<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

4 min read

SmartTRAK Announces Software Advancements & Launches Insights Reports for Emerging Orthopedic/Spine and Wound Medtech Markets

By Gabriele Nichols on 10/18/23 10:15 AM

New SaaS technology offering delivers competitive advantage in rapidly changing Ambulatory Surgery Center market.

SmartTRAK, the leading global Medtech business and market software intelligence solution in the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets, announces the release of enhanced software products and strategic reports available for purchase in Q4 to help clients position themselves for growth in 2024 and beyond.

Powered by industry experts and data analysts, SmartTRAK's Insights-as-a-Service platform is the Medtech industry's only "all-in-one" solution that delivers market insights and business intelligence via an intuitive SaaS platform. Designed to reduce the redundancies in market research, SmartTRAK compiles and curates insights from hundreds of disparate information sources into its highly valued SmartTRAK Daily Updates, comprehensive market overviews and simple-to-use tools and dashboards for market, product and financial analysis.

Continue Reading
1 min read

Wallaby Acquires phenox GmBH

By Anne Staylor on 4/21/22 6:41 PM

Wallaby Medical announced it has acquired phenox GmbH, including phenox's femtos GmbH, a German-based neurovascular company, for a total of ~$545MM (EUR 500MM) including milestone payments. SmartTRAK previously reported the possibility of the acquisition deal in early March 2022. Wallaby Medical acquiring phenox GmbH is one of the largest recent cross-border transactions in the medical device industry and will enable the Company to provide a wide range of neurovascular solutions to pts in the US, China, Europe, Japan and other international markets.

For more information about phenox, click to read "phenox Takes Aim at US Market with Novel Stroke Devices", SmartTRAK's interview with James Lago, President and CEO of phenox Inc., in which he discusses the Company's novel mechanical thrombectomy device and flow diverter, and what’s next in terms of bringing these technologies to the US market.

Continue Reading
  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles